Jarlier V, Nikaido H
Laboratoire de Bactériologie-Virologie, Faculté de Médecine Pitié-Salpêtrière, Paris, France.
FEMS Microbiol Lett. 1994 Oct 15;123(1-2):11-8. doi: 10.1111/j.1574-6968.1994.tb07194.x.
Mycobacteria show a high degree of intrinsic resistance to most antibiotics and chemotherapeutic agents. The low permeability of the mycobacterial cell wall, with its unusual structure, is now known to be a major factor in this resistance. Thus hydrophilic agents cross the cell wall slowly because the mycobacterial porin is inefficient in allowing the permeation of solutes and exists in low concentration. Lipophilic agents are presumably slowed down by the lipid bilayer which is of unusually low fluidity and abnormal thickness. Nevertheless, the cell wall barrier alone cannot produce significant levels of drug resistance, which requires synergistic contribution from a second factor, such as the enzymatic inactivation of drugs.
分枝杆菌对大多数抗生素和化疗药物表现出高度的内在抗性。现已知道,具有特殊结构的分枝杆菌细胞壁的低通透性是造成这种抗性的一个主要因素。因此,亲水性药物穿过细胞壁的速度很慢,因为分枝杆菌孔蛋白在允许溶质渗透方面效率低下且浓度较低。亲脂性药物可能会因流动性异常低且厚度异常的脂质双层而减缓渗透速度。然而,仅细胞壁屏障并不能产生显著水平的耐药性,这需要第二个因素的协同作用,例如药物的酶促失活。